Effect of transdermal estradiol and oral conjugated equine estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
Wakatsuki
Akihiko
A
Okatani
Yuji
Y
Fukaya
Takao
T
D000284:Administration, Oral; D002097:C-Reactive Protein / Q000032:analysis*; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000453:epidemiology; D020405:Dermis; D004958:Estradiol / Q000008:administration & dosage / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017698:Postmenopause; D012176:Retinoids / Q000494:pharmacology; D012307:Risk Factors
D004966:Estrogens, Conjugated (USP); D012176:Retinoids; D004958:Estradiol; D002097:C-Reactive Protein